JANE JESSE: Open Payments
NPI 1508060112 · KINGSTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$109,585 in 117 payments from 9 companies in 2025. Trend: 2023 $82,095 · 2024 $124,977 · 2025 $109,585
Speaker / faculty: $83,006Consulting: $13,465Travel & lodging: $10,529Food & beverage: $2,585
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 107 | $109,329 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $77 |
| Indivior Inc. | 2 | $41 |
| Alkermes, Inc. | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $17 |
| Braeburn Inc. | 1 | $15 |
Products named: AUSTEDO XR, UZEDY, CAPLYTA, SUBLOCADE, ARISTADA, SPRAVATO, INGREZZA, FANAPT.
Industry payments across PA — which companies pay providers there.
